Literature DB >> 29336252

Colchicine in Gout: An Update.

Tristan Pascart1,2, Pascal Richette3,4.   

Abstract

Despite the fact that colchicine is by far the most ancient treatment for gout, new data are still being gathered. In gout, colchicine's ability to block polymerization of tubulin prevents the activation of the inflammasome. Efficacy of colchicine for the treatment of gout flares has been demonstrated only recently by a randomized- controlled trial, but it still has not been compared to other drugs. Use of colchicine is impaired by the impact of underlying comorbid conditions and drug interactions that can considerably modify its pharmacokinetics and pharmacodynamics. This manuscript reviews the state-of-the-art of colchicine in gout, from its known mechanisms of action to its effects, wanted and unwanted, expected and unexpected. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Colchicine; drugs; gout; pharmacodynamics; pharmacokinetics; tubulin.

Mesh:

Substances:

Year:  2018        PMID: 29336252     DOI: 10.2174/1381612824999180115103951

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  12 in total

1.  Microtubules as a potential platform for energy transfer in biological systems: a target for implementing individualized, dynamic variability patterns to improve organ function.

Authors:  Yaron Ilan
Journal:  Mol Cell Biochem       Date:  2022-07-13       Impact factor: 3.842

Review 2.  The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis.

Authors:  Jiwen Fan; Meng Ren; Binay Kumar Adhikari; Haodong Wang; Yuquan He
Journal:  J Inflamm Res       Date:  2022-07-07

3.  Investigation of the Effects and Mechanisms of Dendrobium loddigesii Rolfe Extract on the Treatment of Gout.

Authors:  Kai-Hui Zhang; Mei-Qi Wang; Lu-Ling Wei; Cheng-Jing Feng; Yu-Si Zhang; Jian-Bei Teng
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-30       Impact factor: 2.629

4.  The use of anti-interleukin-1 agents and tumor necrosis factor-alpha inhibitors in renal transplant recipients.

Authors:  Veli Yazısız; Vural Taner Yılmaz; İsmail Uçar; Özgür Dandin; Bengisu Aslan; Funda Erbasan; Hüseyin Koçak; Mustafa Ender Terzioğlu
Journal:  Arch Rheumatol       Date:  2021-01-14       Impact factor: 1.472

Review 5.  Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis.

Authors:  Omer Gendelman; Howard Amital; Nicola Luigi Bragazzi; Abdulla Watad; Gabriel Chodick
Journal:  Autoimmun Rev       Date:  2020-05-05       Impact factor: 9.754

Review 6.  Relationship between hyperuricemia with deposition and sexual dysfunction in males and females.

Authors:  A Sansone; Y Reisman; E A Jannini
Journal:  J Endocrinol Invest       Date:  2022-01-08       Impact factor: 5.467

7.  From the North Sea to Drug Repurposing, the Antiseizure Activity of Halimide and Plinabulin.

Authors:  Daniëlle Copmans; Sara Kildgaard; Emma Roux; Michèle Partoens; Gert Steurs; Xinhui Wang; Wim M De Borggraeve; Camila V Esguerra; Alexander D Crawford; Thomas O Larsen; Peter A M de Witte
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-18

Review 8.  The Role of Colchicine in Atherosclerosis: From Bench to Bedside.

Authors:  Leticia González; Juan Francisco Bulnes; María Paz Orellana; Paula Muñoz Venturelli; Gonzalo Martínez Rodriguez
Journal:  Pharmaceutics       Date:  2022-07-01       Impact factor: 6.525

Review 9.  A brief review on in vivo models for Gouty Arthritis.

Authors:  Tulsi Patil; Arun Soni; Sanjeev Acharya
Journal:  Metabol Open       Date:  2021-06-14

10.  Chronic colchicine poisoning with neuromyopathy, gastric ulcers and myelosuppression in a gout patient: A case report.

Authors:  Meng-Mei Li; Jun Teng; Yan Wang
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.